ASH/FDA Workshop on Clinical Endpoints in Multiple Myeloma

October 26, 2006
Washington, DC

Workshop Agenda

Participant List

PRESENTATIONS:

FDA Regulatory Background
Ann Farrell, MD, and Robert Kane, MD

Scope and Background of Panel
Kenneth C. Anderson, MD

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Robert A. Kyle, MD

Newly Diagnosed Myeloma
S. Vincent Rajkumar, MD

Maintenance Therapy
Keith Stewart, MD

Early Relapse
Donna Weber, MD

Relapsed and Refractory Multiple Myeloma
Paul G. Richardson, MD